Psoralen-mediated photodecontamination of platelet concentrates: Inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo

Transfusion

Volumn 37, Issue 9, 1997, Pages 889-895

  Margolis Nunno, H ^a   Bardossy, L ^b   Robinson, R ^c   Ben Hur, E ^c   Horowitz, B ^c   Blajchman, M A ^d  

^a NEW YORK BLOOD CENTER   (United States)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^c Strat Plan and Program Management   (United States)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4' AMINOMETHYL 4,5',8 TRIMETHYLPSORALEN; RUTOSIDE; THROMBOCYTE CONCENTRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING TIME; CONTROLLED STUDY; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LATENT VIRUS INFECTION; NONHUMAN; RABBIT; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; THROMBOCYTOPENIA; ULTRAVIOLET A RADIATION; VIRUS INACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0030804597     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37997454013.x     Document Type: Article

References (33)

1. Dodd RY. The risk of transfusion-transmitted infection (editorial). N Engl J Med 1992;327:419-21.
2. Wagner SJ, Friedman LI, Dodd RY. Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma. Transfus Med Rev 1991;5:18-32.
3. Ben-Hur E, Moor AC, Margolis-Nunno H, et al. The photodecontamination of cellular blood components: mechanisms and use of photosensitization in transfusion medicine. Transfus Med Rev 1996;10:15-22.
4. Lin L, Wiesehahn GP, Morel PA, Corash L. Use of 8-methoxypsoralen and long-wavelength ultraviolet radiation for decontamination of platelet concentrates. Blood 1989;74:517-25.
5. Lin L, Londe H, Janda JM, et al. Photochemical inactivation of pathogenic bacteria in human platelet concentrates. Blood 1994;83:2698-706.
6. Dodd RY, Moroff G, Wagner S, et al. Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methods. Transfusion 1991;31:483-90.
7. Margolis-Nunno H, Williams B, Rywkin S, et al. Virus sterilization in platelet concentrates with psoralen and ultraviolet A light in the presence of quenchers. Transfusion 1992;32:541-7.
8. Margolis-Nunno H, Robinson R, Ben-Hur E, Horowitz B. Quencher-enhanced specificity of psoralen-photosensitized virus inactivation in platelet concentrates. Transfusion 1994;34:802-10.
9. Margolis-Nunno H, Robinson R, Horowitz B, et al. Psoralen-mediated virus photoinactivation in platelet concentrates: enhanced specificity of virus kill in the absence of shorter UVA wavelengths. Photochem Photobiol 1995;62:917-22.
10. Gottlieb P, Margolis-Nunno H, Robinson R, et al. Inactivation of Trypanosoma cruzi trypomastigote forms in blood components with a Psoralen and Ultraviolet A light. Photochem Photobiol 1996;63:562-5.
11. Blajchman MA, Senyi AF, Hirsh J, et al. Hemostatic function, survival, and membrane glycoprotein changes in young versus old rabbit platelets. J Clin Invest 1981;68:1289-94.
12. Wagner SJ, Bardossy L, Moroff G, et al. Assessment of the hemostatic effectiveness of human platelets treated with aminomethyltrimethyl psoralen and UV A light using a rabbit ear bleeding time technique. Blood 1993;82:3489-92.
13. Ali AM, Warkentin TE, Bardossy L, et al. Platelet concentrates stored for 5 days in a reduced volume of plasma maintain hemostatic function and viability. Transfusion 1994;34:44-7.
14. Chesebro B, Wehrly K. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol 1988;62:3779-88.
15. Chesebro B, Buller R, Portis J, et al. Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. J Virol 1990;64:215-21.
16. Chesebro B, Wehrly K, Metcalf J, et al. Use of a new CD4-positive HeLa cell clone for direct quantitation of infectious human immunodeficiency virus from blood cells of AIDS patients. J Infect Dis 1991;163:64-70.
17. Pincus SH, Wehrly K, Chesebro B. Use of a focal infectivity assay for testing susceptibility of HIV to antiviral agents. Biotechniques 1991;10:336-42.
18. Folks TM, Justement J, Kinter A, et al. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987;238:800-2.
19. Clouse KA, Powell D, Washington I, et al. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol 1989;142:431-8.
20. Folks TM, Clouse KA, Justement J, et al. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A 1989;86:2365-8.
21. Butera ST, Roberts BD, Lam L, et al. Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency. J Virol 1994;68:2726-30.
22. Butera ST, Roberts BD, Leung K, et al. Tumor necrosis factor receptor expression and signal transduction in HIV-1-infected cells. AIDS 1993;7:911-8.
23. + model of chronic infection. J Immunol 1993;150:625-34.
24. Horowitz B, Williams B, Rywkin S, et al. Inactivation of viruses in blood with aluminum phthalocyanine derivatives. Transfusion 1991;31:102-8.
25. Watson AJ, Klaniecki J, Hanson CV. Psoralen/UV inactivation of HIV-1-infected cells for use in cytologic and immunologic procedures. AIDS Res Hum Retroviruses 1990;6:503-13.
26. Lin L, Londe H, Hanson CV, et al. Photochemical inactivation of cell-associated human immunodeficiency virus in platelet concentrates. Blood 1993;82:292-7.
27. Benade LE, Shumaker J, Xu Y, et al. Inactivation of free and cell-associated human immunodeficiency virus in platelet suspensions by aminomethyltrimethylpsoralen and ultraviolet light. Transfusion 1994;34:680-4.
28. Beer JZ, Olvey KM, Lee W, et al. Reassessment of the differential effects of ultraviolet and ionizing radiation on HIV promoter: the use of cell survival as the basis for comparisons. Photochem Photobiol 1994;59:643-9.
29. Zmudzka BZ, Strickland AG, Miller SA, et al. Activation of the human immunodeficiency virus promoter by UVA radiation in combination with psoralens and angelicins. Photochem Photobiol 1993;58:226-32.
30. Legrand-Poels S, Hoebeke M, Vaira D, et al. HIV-1 promoter activation following an oxidative stress mediated by singlet oxygen. J Photochem Photobiol B 1993;17:229-37.
31. Ben-Hur E, Song PS. Photochemistry and photobiology of furocoumarins (psoralens). Adv Radiat Biol 1984;11:131-71.
32. Zmudzka BZ, Strickland AG, Beer JZ, Ben-Hur E. Photosensitized decontamination of blood with the silicon phthalocyanine Pc 4: no activation of the human immunodeficiency virus promoter. Photochem Photobiol 1997;65:461-4.
33. Lee TH, Stromberg RR, Henrard D, Busch MP. Effect of platelet-associated virus on assays of HIV-1 in plasma (letter). Science 1993;262:1585-6.